Lung Cancer presents a heavy health and economic burden in Asia, being the most common form of cancer, with 60% of the world’s lung cancers being diagnosed there. Lung cancer is also present in more than 30% of non-smokers in Asia, specifically in adenocarcinomas, which is a subtype largely defined by oncogenic driver gene mutations. Compared to that, in western countries, only about 10% of lung cancer patients are non-smokers.
Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) are common sites for driver gene mutations; which are believed to vary significantly based on ethnicities, with EGFR mutations being present in about 15% of a...
